ZNF554

ZNF554 is a transcription factor that functions predominantly as a repressor of oncogenic gene programs while exerting antioxidant cytoprotection, with roles documented in trophoblast biology and in glioblastoma and endometrial cancer cells (PMID:30135684, PMID:32796700). As a regulator of placental gene modules, loss of ZNF554 through promoter-region DNA hypermethylation impairs trophoblast invasion and is associated with preterm preeclampsia (PMID:30135684). In trophoblasts, ZNF554 sustains antioxidant capacity by activating the p62-Keap1-NRF2 pathway; its loss elevates mitochondrial ROS, increases apoptosis, and promotes autophagy through suppression of p62 and accumulation of LC3-II, effects partially reversed by the antioxidant NAC (PMID:37804692). ZNF554 directly activates transcription of RBM5, and through RBM5 inactivates WNT/β-catenin signaling, reducing β-catenin and p-GSK-3β and thereby constraining proliferation and migration (PMID:38619681). More broadly, ZNF554 overexpression downregulates hundreds of genes, arrests the cell cycle, and suppresses proliferation, with the PI3K-Akt pathway most strongly affected, consistent with its role as a transcriptional repressor of oncogenic signaling (PMID:32796700).

1. 2018 Medium

   Establishing that ZNF554 is an epigenetically silenced hub transcription factor answered how its dysregulation links to a disease phenotype, identifying methylation-driven down-regulation as the trigger for impaired trophoblast invasion in preterm preeclampsia.

   Evidence Placental transcriptomics and in vitro ZNF554 modulation in trophoblast cells

   PMID:30135684

   Open questions at the time

   • Direct transcriptional targets in trophoblasts not yet identified
   • Which enzymes set the regulatory-region methylation is unknown
   • No structural or DNA-binding-site characterization
2. 2020 Medium

   Genome-wide overexpression profiling answered whether ZNF554 acts as an activator or repressor, showing it predominantly downregulates genes, arrests the cell cycle, and most strongly impacts PI3K-Akt signaling, establishing it as a transcriptional repressor of oncogenic programs.

   Evidence Transient overexpression in U87 glioblastoma cells with transcriptomics, proliferation, and cell-cycle assays

   PMID:32796700

   Open questions at the time

   • Direct vs indirect targets not distinguished by transcriptomics alone
   • No ChIP evidence for direct binding to the affected loci
   • Repression mechanism (cofactors, KRAB corepressors) not defined
3. 2023 Medium

   Loss- and gain-of-function in trophoblasts answered how ZNF554 protects cells from oxidative stress, linking it to the p62-Keap1-NRF2 axis and showing its loss raises ROS and shifts cells toward apoptosis and autophagy.

   Evidence siRNA knockdown/overexpression in HTR8/SVneo and JEG3 cells, ROS and apoptosis assays, NRF2-pathway Western blots, NAC rescue

   PMID:37804692

   Open questions at the time

   • Whether ZNF554 regulates p62/NRF2 components transcriptionally and directly is unresolved
   • Mechanism connecting ZNF554 to mitochondrial ROS is indirect
   • NAC only partially rescued the phenotype
4. 2024 Medium

   ChIP and reporter assays with epistasis rescue answered which direct target mediates ZNF554's anti-proliferative effect, placing ZNF554 upstream of RBM5, which in turn inactivates WNT/β-catenin signaling.

   Evidence ChIP, luciferase reporter, lentiviral over/knockdown in endometrial cancer cells, proliferation/invasion assays, RBM5 rescue

   PMID:38619681

   Open questions at the time

   • ZNF554 binding motif on the RBM5 promoter not mapped
   • Whether RBM5 fully accounts for the broader repressive program is unknown
   • Single cancer-type context for the RBM5-WNT link

• Whether the distinct ZNF554 activities — RBM5/WNT repression, NRF2 antioxidant activation, and PI3K-Akt suppression — reflect one unified DNA-binding program or context-specific target sets remains unresolved.
• No genome-wide DNA-binding map (ChIP-seq) across cell types
• No structural characterization of the zinc-finger array or KRAB-mediated repression
• Direct vs indirect status of most regulated genes undetermined